Max van Hogerlinden
- Molecular Biology
- Cancer Research top 10%
- Endocrinology, Diabetes and Metabolism top 5%
- Immunology
- Oncology
- Co-authors
- Rune ToftgårdBjörn RozellLars Ährlund‐RichterKristina NordströmKarin WallisBjörn VennströmJens MittagDerek Tobin
- Topics
- NF-κB Signaling Pathways (5 papers)Thyroid Disorders and Treatments (5 papers)Immune Response and Inflammation (3 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of NeuroscienceThe Journal of Clinical Endocrinology & Metabolism
- Partner nations
- SwedenIndiaUnited States
In The Last Decade
Max van Hogerlinden
12 papers receiving 746 citations
Peers
Comparison fields: 5 of 73
- Molecular Biology 325
- Cancer Research 304
- Endocrinology, Diabetes and Metabolism 223
- Immunology 187
- Oncology 165
Countries citing papers authored by Max van Hogerlinden
This map shows the geographic impact of Max van Hogerlinden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max van Hogerlinden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max van Hogerlinden more than expected).
Fields of papers citing papers by Max van Hogerlinden
This network shows the impact of papers produced by Max van Hogerlinden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max van Hogerlinden. The network helps show where Max van Hogerlinden may publish in the future.
Co-authorship network of co-authors of Max van Hogerlinden
This figure shows the co-authorship network connecting the top 25 collaborators of Max van Hogerlinden. A scholar is included among the top collaborators of Max van Hogerlinden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max van Hogerlinden. Max van Hogerlinden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 2 | |
| 3 | 50 | |
| 4 | 8 | |
| 5 | 114 | |
| 6 | 21 | |
| 7 | 101 | |
| 8 | 34 | |
| 9 | 89 | |
| 10 | 38 | |
| 11 | Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. | 232 |
| 12 | 49 |
About Max van Hogerlinden
Max van Hogerlinden is a scholar working on Developmental Neuroscience, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 12 papers that have together received 756 indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (5 papers), Thyroid Disorders and Treatments (5 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Cancer Research (304 citations), Endocrinology, Diabetes and Metabolism (223 citations) and Immunology (187 citations). Max van Hogerlinden has collaborated with scholars based in Sweden, India and United States. Frequent co-authors include Rune Toftgård, Björn Rozell, Lars Ährlund‐Richter, Kristina Nordström, Karin Wallis, Björn Vennström, Jens Mittag, Derek Tobin, Robert P. A. Wallin and Hans‐Gustaf Ljunggren. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.